Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.52 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.41 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.41 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.41 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22028153 | 1.00 | GPR84 (0.52) | GPR84FFAR1FFAR4KDM4EDUSP3 | |
| SCHEMBL26965739 | 0.87 | FAAH (0.51) | FFAR1FFAR4KDM4EDUSP3LMNA | |
| SCHEMBL29660804 | 0.84 | GPR84 (0.53) | GPR84FFAR1FFAR4ZDHHC7 | |
| SCHEMBL10869134 | 0.84 | GPR84 (0.57) | GPR84FFAR1FFAR4KDM4EDUSP3 | |
| SCHEMBL29033353 | 0.84 | GPR84 (0.57) | GPR84FFAR1FFAR4KDM4EDUSP3 | |
| SCHEMBL353980 | 0.77 | GPR84 (0.63) | GPR84FFAR1FFAR4ZDHHC7MAPT | |
| SCHEMBL353158 | 0.77 | GPR84 (0.63) | GPR84FFAR1FFAR4ZDHHC7MAPT | |
| SCHEMBL353503 | 0.77 | GPR84 (0.63) | GPR84FFAR1FFAR4ZDHHC7MAPT | |
| SCHEMBL6037463 | 0.77 | GPR84 (0.63) | GPR84FFAR1FFAR4ZDHHC7MAPT | |
| SCHEMBL6663357 | 0.77 | GPR84 (0.50) | GPR84FFAR1ZDHHC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023122602-A1 | SHORT-PATH EVAPORATION PROCESSES | CARGILL, INCORPORATED (US) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023122598-A1 | SHORT-PATH EVAPORATION PROCESSES | CARGILL, INCORPORATED (US) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023122604-A1 | SHORT-PATH EVAPORATION PROCESSES | CARGILL, INCORPORATED (US) | 2023-06-29 | — | — | WO | disclosed |
| US-11540987-B2 | Composition with stabilized taste and odor (II) | SYMRISE AG (DE) | 2023-01-03 | — | — | US | disclosed |
| EP-3777981-A1 | A MIXTURE WITH STABILIZED TASTE AND/OR ODOR | Symrise AG (DE) | 2021-02-17 | — | — | EP | disclosed |
| EP-3386595-B1 | COMPOSITION WITH STABILIZED TASTE AND ODOR | SYMRISE AG (DE) | 2020-11-25 | — | — | EP | disclosed |
| US-20200179252-A1 | COMPOSITION WITH STABILIZED TASTE AND ODOR (II) | SYMRISE AG (DE) | 2020-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200179252-A1 | COMPOSITION WITH STABILIZED TASTE AND ODOR (II) | TAS2R16, TAS2R20, TAS2R1 | GPR84 1346/4885FFAR1 38/4885FFAR4 97/4885 |
| US-11540987-B2 | Composition with stabilized taste and odor (II) | TAS2R16, TAS2R20, TAS2R1 | GPR84 1346/4885FFAR1 38/4885FFAR4 97/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.